LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Tests for Acute Rhinosinusitis Infections Reviewed

By LabMedica International staff writers
Posted on 28 Oct 2016
Print article
Acute rhinosinusitis (ARS) is defined as inflammation of the paranasal sinuses caused by viral or bacterial infection, and typically presents with facial pain or pressure, purulent nasal discharge, fever, cacosmia or hyposmia, and double sickening.

Many patients who see physicians for sinus infections expect to be prescribed an antibiotic, but for the majority of them, that course of treatment will not be effective. Unfortunately, there are not great diagnostic tools to determine which patients will or will not benefit from antibiotics.

Medical scientists at the University of Georgia (Athens, GA, USA) analyzed 30 studies of outpatients with a respiratory tract infection to see which diagnostic criteria, if any, were most accurate for diagnosing sinus infection. These included studies of adults and children with clinically suspected sinusitis or acute respiratory tract infection that reported the accuracy of at least one blood test or imaging study for ARS or acute bacterial rhinosinusitis (ABRS). Acceptable reference standards included radiography, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) for ARS, and antral puncture revealing purulent fluid or fluid yielding a positive culture for ABRS.

Blood tests studied included C-reactive protein (CRP), white blood cell count (WBC), and the erythrocyte sedimentation rate (ESR), and other tests included rhinoscopy, a test of nasal secretions, and the accuracy of scintigraphy. An ESR of greater than 10 is limited evidence against a diagnosis of acute rhinosinusitis, while an ESR of greater than 30 or 40 provide moderate evidence in favor of the diagnosis. Similarly, a CRP of less than 10 mg/L was limited evidence against a diagnosis of ARS while a CRP of greater than 20 mg/L is limited evidence in favor of the diagnosis. Only one of the four studies of CRP used antral puncture as the reference standard, and it had generally similar results to the imaging studies.

The authors concluded that in general, tests were of limited value in the diagnosis of ARS. Normal radiography helps rule out sinusitis when negative, whereas CRP and ESR help rule in sinusitis when positive, although, given their limited accuracy as individual tests, they cannot be routinely recommended. Prospective studies integrating signs and symptoms with point-of-care CRP, dipstick, and/ or handheld B-mode ultrasound are needed.

Mark H. Ebell, MD, a professor and lead author of the study said, “The use of C-reactive protein is promising as a point of care test to reduce the overuse of antibiotics. There have been several studies in Europe showing that in the primary care setting, having the CRP results that show a patient is unlikely to have bacterial sinusitis, doctors are more confident about not using antibiotics and they've reduced inappropriate antibiotics use.” The study was published on September 1, 2016, in the British Journal of General Practice.

Related Links:
University of Georgia

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.